EUVIMEDEUVIMED entdecken
Crossref

Course and complications of influenza A in seniors over 65 years of age

Dalibor Sedláček, Robin Šín, Patrik Christian Cmorej, Miroslav Kubiska

Central European Journal of Public Health · 2024

DOI: 10.21101/cejph.a7877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Central European Journal of Public Health, 2024. Verfasst von Dalibor Sedláček und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Travel Medicine, Faculty of Medicine in Pilsen and University Hospital Pilsen, Charles University, Pilsen, Czec…. Hauptthemen laut MEDLINE: Influenza, Human, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: Influenza A and B viruses cause epidemics every year, with approximately 3-5 million serious cases and about 290,000 to 650,000 deaths worldwide. Most patients die from bacterial complications of influenza. The aim of our study was to describe the clinical pictures of influenza and the development of the complications in seniors over 65 years of age, who were treated in University Hospital Pilsen. The course of the disease and changes in laboratory parameters were evaluated with regard to the method of treatment performed. METHODS: A descriptive retrospective study was performed. Clinical and laboratory data of seniors with the diagnosis of influenza were extracted from electronic medical records and later analysed. The data were processed with Excel 2016 and Statistica. RESULTS: A collection of 261 seniors, of whom 218 were hospitalized and 43 treated in an outpatient setting, has been studied. Patients who later developed complications had elevated values of CRP, procalcitonin, urea, and creatinine. The antiviral drug oseltamivir was administered to 226 of 261 seniors. Forty-seven seniors (18.0%) died from influenza and its complications (severe pneumonia with acute respiratory insufficiency or heart failure). CONCLUSIONS: The course of influenza in seniors was usually more severe and required hospitalization along with antiviral treatment. The mortality rate in the monitored group exceeded 18%. Annual timely vaccination, but also other preventive measures, and maybe considering other risk groups are methods to prevent severe or even fatal cases of influenza.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanAntiviral AgentsHumansAgedMaleFemaleRetrospective StudiesAged, 80 and overInfluenza A virusOseltamivirHospitalization

Stichwörter der Autor:innen

complicationsinfluenzarespiratory infectionsseniorsvaccination

Substanzen

Antiviral AgentsOseltamivir

Autor:innen und Institutionen

  • Department of Infectious Diseases and Travel Medicine, Faculty of Medicine in Pilsen and University Hospital Pilsen, Charles University, Pilsen, Czech Republic.
  • Faculty of Health Studies, Jan Evangelista Purkyne University, Usti nad Labem, Czech Republic.

Zitieren

APA

Sedláček, D., Šín, R., Cmorej, P. C., & Kubiska, M. (2024). Course and complications of influenza A in seniors over 65 years of age. Central European Journal of Public Health. https://doi.org/10.21101/cejph.a7877

Vancouver

Sedláček D, Šín R, Cmorej PC, Kubiska M. Course and complications of influenza A in seniors over 65 years of age. Central European Journal of Public Health. 2024. doi:10.21101/cejph.a7877

BibTeX
@article{Sedlek2024,
  author = {Sedláček, Dalibor and Šín, Robin and Cmorej, Patrik Christian and Kubiska, Miroslav},
  title = {Course and complications of influenza A in seniors over 65 years of age},
  journal = {Central European Journal of Public Health},
  year = {2024},
  doi = {10.21101/cejph.a7877}
}
Kostenlos starten →